AI-researched · adversarially reviewed · human-checked · corrections public
BEFORE YOU READ — HOW DO YOU RULE?
The Verdict
The annual "full-body checkup" is a product, not a medical recommendation. Randomized trials of general health checks keep finding no reduction in deaths — while the 60-test panels reliably produce false alarms, incidental findings, overdiagnosis, and follow-up cascades that hospitals bill happily. A short list of specific, targeted screenings genuinely saves lives. The executive package is marketing wrapped around that list, with the profitable noise added back in.
strongThe targeted core genuinely works: blood pressure checks, cervical screening, colon screening at the right age, HbA1c/glucose in at-risk adults, lipids for risk scoring. These have outcome evidence, individually.
moderateLikely improves detection and management of hypertension and diabetes when part of ongoing primary care (as opposed to a yearly hotel-style event).
weakMay provide reassurance and a doctor relationship some people otherwise never get — worth something, though it is not what the brochure sells.
§ What it doesn't do
Where the marketing outruns the data
contradictedDoes not reduce overall or cardiovascular or cancer mortality — the Cochrane review of randomized trials of general health checks (250,000+ participants) found none, despite marketing built entirely on "early detection saves lives."
contradictedTumor-marker panels (CEA, CA-125, CA 19-9, AFP…) in symptomless people do not work as cancer screening: there is no evidence of benefit and a well-documented harvest of false positives and needless scans.
contradictedWhole-body CT/MRI screening of healthy people is recommended AGAINST by radiology bodies themselves — the incidentaloma yield is enormous and the proven benefit absent.
strongMore tests do not mean more safety: each extra test on a healthy person raises the odds the package finds something meaningless to act on.
§ The Money Map
Who profits, stage by stage
The packagePanels bundle cheap automated tests and price the bundle as premium prevention ("Executive", "Platinum", "Whole Body"). Marginal cost per extra test is trivial; perceived value scales with test count — the incentive is to add noise.
The funnelThe package is often a loss-leader. The margin lives downstream: every borderline result and incidentaloma converts a healthy customer into a patient — scans, biopsies, consultations, sometimes surgery. The cascade is the business model.
The corporate channelEmployer tie-ups and insurance bundles deliver bulk healthy customers annually. In India, hospital chains advertise packages the way airlines advertise seat sales.
The slogan"Early detection saves lives" is true for specific screenings and false as a general principle — the Korea thyroid episode (screening boom → 15× more "cancer" → zero change in deaths) is the definitive receipt.
This pageNo hospital sponsorship, no lab affiliates. See "How we make money."
§ The other side
The strongest case against this verdict
The strongest case against our verdict: the trials behind the Cochrane null are old, mostly European, and predate modern risk scoring and treatments — a well-designed contemporary check focused on blood pressure, lipids, diabetes and risk-appropriate cancer screening might do better than those historical programs. Checks also find genuinely treatable things (severe hypertension, diabetes) in people disconnected from care — for someone who will otherwise see no doctor for a decade, one structured encounter has option value the averages hide. The rational conclusion is "do the targeted list," not "do nothing."
§ Symmetric harms
Harms of using it — and of avoiding it
If you use it
False positives: across a 60-test panel, statistically expect several abnormal results in a perfectly healthy person — each one a doorway to anxiety and follow-up.
Overdiagnosis: real "cancers" that would never have hurt you, treated with real surgery and real complications (Korea, thyroid).
Radiation from CT-containing packages; money — often out of pocket; and false reassurance in the other direction ("all clear" ≠ healthy).
If you avoid it
Skipping the TARGETED list is genuinely dangerous: unmeasured blood pressure, missed cervical/colon screening, undiagnosed diabetes kill quietly. Do not let package-skepticism become screening-nihilism.
People with symptoms: this verdict is about symptomless screening — investigating actual symptoms is not optional.
§ The Minority Report
Who gets hurt when it goes right for everyone else
The hurt group is the healthy: the fitter you are, the worse the package's math treats you.
Healthy young adults buying "peace of mind": near-zero prior probability of disease means most abnormal results are false — they buy anxiety at a premium.
Incidentaloma patients: the thyroidectomies, adrenal workups, and lung biopsies triggered by findings that would never have mattered — with lifelong medication or complications for some.
The scanned-and-irradiated: annual CT-containing packages accumulate radiation exposure with no proven benefit.
The falsely reassured: a "clear" package after which real symptoms get dismissed for months.
How to tell if you might be in this group: Ask of every test in the package: "What guideline recommends this for a symptomless person of my age and risk — and what happens next if it comes back borderline?" A test with no good answer to both is decoration.
§ The alternatives ledger
Everything else, judged by the same standards
strong
Guideline-based targeted screening (age/risk-specific) The evidence-backed core: BP, cervical, colon, lipids, diabetes when at risk, lung CT only for heavy smokers. Cheap, boring, effective.
strong
A home blood-pressure monitor Probably the highest-value 3,000-rupee "checkup" that exists — the killer condition it tracks is common, silent, and treatable.
moderate
Knowing your family history Free, and changes screening recommendations more than most lab panels do.
none
Full-body MRI startups The premium reincarnation of the same product; radiology societies still recommend against screening the symptomless. There is no outcome evidence — only better fonts.
§ The AI Showdown
What other AIs tell you when you ask
We asked each AI the plain question a normal person types: “Are annual full-body checkup packages worth getting?”
ChatGPT
gpt-5.5 · Oct 11, 2026
6/10
A clinically sound, well-structured answer that reaches the right conclusion and gives a usable next step, but it skips the trial evidence and citations entirely and never follows the money behind the package industry.
●●Matches the evidence. It lands on the same bottom line — generic full-body bundles aren't worth it while targeted, age/risk-based screening is — though it never cites the mortality-neutral trial evidence (Cochrane) that anchors the verdict.
●○Names the harms. It names false positives, anxiety, unnecessary biopsies, radiation and cost, but doesn't explain who is most hurt (healthy low-risk people), nor mention overdiagnosis, incidentalomas or false reassurance.
○○Follows the money. It mentions cost to the patient but says nothing about who profits, the downstream cascade business model, or 'early detection' marketing pressure.
●○Honest about uncertainty. It appropriately conditions recommendations on age, sex and risk and avoids fake numbers, but offers no sources and no acknowledgement of open questions or the strength of the underlying evidence.
●●Useful next step. It tells the reader to book a preventive visit with a primary-care doctor and gives a concrete question to ask about which screenings fit them, without diagnosing or touching medications.
Read its full answer
Usually, **annual “full-body checkup packages” are not worth it if they’re a large, one-size-fits-all bundle**, especially if they include lots of tests for an otherwise healthy person with no symptoms. They can find useful issues occasionally, but they also often lead to **false positives, anxiety, unnecessary follow-up scans/biopsies, radiation exposure, and extra costs**.
What *is* worth doing is a **personalized preventive health visit** based on your age, sex, family history, lifestyle, symptoms, and existing conditions.
## Often worthwhile in a routine preventive check
Depending on your situation, a doctor may recommend:
- **Blood pressure**, weight/BMI, waist circumference
- **Cholesterol/lipid profile** at appropriate intervals
- **Diabetes screening** — fasting glucose or HbA1c if age/risk factors apply
- **Vaccination review** — flu, COVID, tetanus, HPV, shingles, pneumococcal, hepatitis, etc.
- **Cancer screening when age/risk appropriate**
- Colon cancer screening from around **45** for average-risk adults
- Cervical cancer screening for eligible women
- Breast cancer screening depending on age/risk and local guidelines
- Lung cancer screening only for certain heavy current/former smokers
- **HIV and hepatitis C screening** at least once for many adults
- **STI screening** if risk factors apply
- **Kidney/liver tests, CBC, thyroid tests** only when indicated by risks, medications, symptoms, or prior abnormalities
## Tests commonly included in “full-body packages” that may be low-value
For healthy people without symptoms, these are often not recommended as routine screening:
- Whole-body **CT or MRI**
- Routine **tumor marker blood tests**
- Large vitamin/mineral panels without specific reason
- Extensive hormone panels
- Repeated ECG/stress tests in low-risk people
- Broad allergy/food intolerance panels
- Frequent “executive” blood panels with dozens of markers
## When a package may be reasonable
A checkup package can be useful if it is:
- **Tailored by a clinician**
- Based on your **age, family history, symptoms, and risks**
- Avoids unnecessary imaging/tumor markers
- Includes a proper consultation to interpret results and plan follow-up
## Bottom line
Rather than buying a generic “full-body checkup,” it’s usually better to schedule a **preventive care visit with a primary-care doctor** and ask: *“Which screening tests are appropriate for me this year?”* That tends to be safer, cheaper, and more evidence-based.
Gemini
gemini-3.5-flash · Oct 11, 2026
9/10
A well-calibrated, conditional answer that lands on the same verdict as the evidence and covers harms and next steps thoroughly, weakened mainly by thin treatment of the business incentives and the missing randomized-trial mortality evidence.
●●Matches the evidence. Reaches the same bottom line — commercial full-body packages aren't worth it for asymptomatic adults while a targeted, age-based screening list is — and correctly cites USPSTF/NHS-type guidance, though it omits the Cochrane mortality finding that is the strongest single receipt.
●●Names the harms. Names false positives and cascades, overdiagnosis of harmless nodules/slow cancers, unnecessary biopsies and surgery, false reassurance, and cost, and identifies healthy low-risk people as those most affected.
●○Follows the money. Notes that packages are heavily marketed by private hospitals/labs and bundle unnecessary tests to justify a higher price, but doesn't explain the downstream cascade-as-revenue model or research funding.
●●Honest about uncertainty. Gives conditional, age- and risk-stratified advice with ranges (e.g., mammography 40–50, PSA as a discussion) and avoids naked percentages or universal claims.
●●Useful next step. Directs the reader to a primary care clinician to order risk-appropriate tests, lists concrete screenings to raise, and makes no diagnosis or medication instruction.
Read its full answer
The short answer is: **For most healthy, young-to-middle-aged adults, commercial "full-body" checkup packages are generally not worth it, and medical organizations often advise against them.**
However, **targeted, age-appropriate health screenings** are highly valuable.
There is a major difference between a personalized annual exam with a primary care physician and a commercial lab package that runs dozens of unrequested blood tests, scans, or imaging on a healthy person.
Here is a detailed breakdown of why these packages are so popular, why medical experts urge caution, and what you should actually do instead.
---
### The Pros: Why People Get Them
Full-body checkup packages—often marketed heavily by private hospitals and diagnostic labs—do offer some real benefits:
1. **Catching "Silent" Conditions:** Certain common health issues show no symptoms in their early stages. Basic panels reliably catch conditions like high blood pressure, high cholesterol, pre-diabetes/type 2 diabetes, and liver or kidney dysfunction.
2. **Establishing a Baseline:** Having regular data on your blood sugar, lipid profiles, and thyroid function gives your doctor a benchmark to compare against as you age.
3. **Behavioral Motivation:** Sometimes, seeing a "borderline" test result is the exact wake-up call a person needs to improve their diet, start exercising, or stop smoking.
---
### The Cons: Why Medical Experts Caution Against Them
Major medical guidelines (such as those from the U.S. Preventive Services Task Force and the UK's NHS) generally discourage blanket, routine testing for asymptomatic individuals. Here’s why:
1. **The "Cascade Effect" (False Positives):** No medical test is 100% accurate. If a package runs 50 different tests on a healthy person, there is a high statistical probability that at least one result will come back slightly abnormal purely by chance. This often leads to unnecessary anxiety, follow-up tests, invasive biopsies, or secondary imaging that carry real physical risks and high out-of-pocket costs—only to discover nothing was wrong.
2. **Overdiagnosis:** Tests like full-body scans or advanced tumor marker panels can detect tiny abnormalities (like benign cysts, harmless nodules, or slow-growing cancers) that would never have caused health problems during your lifetime. Treating them, however, can lead to unnecessary surgery or medication side effects.
3. **False Sense of Security:** A "clean bill of health" from a generic package today does not mean you won't develop a condition tomorrow. Furthermore, standard packages might miss specific conditions if the wrong tests were chosen for your personal genetic background.
4. **Wasted Money:** Many packages bundle expensive, unnecessary tests (like routine ECGs for 25-year-olds or unindicated tumor markers) to make the package look comprehensive and justify a higher price.
---
### What to Do Instead: Evidence-Based Screenings
Instead of buying a "one-size-fits-all" commercial package, healthcare strategies should be **tailored to your age, biological sex, family history, and lifestyle.**
Here is what is generally recommended for healthy individuals:
#### In Your 20s and 30s
* **Blood Pressure:** Checked every 1–2 years.
* **Lipid Panel (Cholesterol) & Blood Glucose:** Checked every 3–5 years (more often if overweight or if family history exists).
* **Cervical Cancer Screening (Women):** Pap smear and/or HPV testing starting at age 21–25.
* **STI Screenings:** As recommended based on sexual activity.
* **Skin Exam:** Annual self-exams or dermatologist checks if at high risk for skin cancer.
#### In Your 40s and 50s
* **All of the above, plus:**
* **Diabetes Screening:** Regular HbA1c or fasting blood glucose tests.
* **Colorectal Cancer Screening:** Starting at age 45 (e.g., colonoscopy or stool-based tests).
* **Breast Cancer Screening (Women):** Mammograms usually starting between ages 40 and 50.
* **Prostate Cancer Screening (Men):** Discussions with a doctor about PSA testing starting around age 50 (earlier if high risk).
#### 60s and Beyond
* **All of the above, plus:**
* **Bone Density Scanning (DEXA):** For women aged 65+ (or younger if at risk).
* **Lung Cancer Screening:** For adults aged 50–80 who have a heavy smoking history.
* **Abdominal Aortic Aneurysm Screening:** One-time ultrasound for men aged 65–75 who have ever smoked.
---
### Bottom Line: How to Decide
* **Skip the commercial super-packages** that offer 80+ indiscriminate tests, full-body CT scans, or tumor markers unless explicitly ordered by a physician.
* **Invest in a relationship with a Primary Care Doctor.** Schedule a routine annual checkup. Let *them* order the specific blood work and screenings you actually need based on your personal health profile and family history. This approach is safer, more effective, and usually far more cost-effective.
*Disclaimer: I am an AI, not a doctor. If you have symptoms, a strong family history of illness, or pre-existing medical conditions, consult a healthcare provider to determine the right screening schedule for you.*
Claude
claude-opus-5 · Oct 11, 2026
9/10
A well-calibrated, evidence-matched answer that lands the same verdict as the key with proportionate harms and caveats, weakened only by a light touch on the commercial incentives driving these packages.
●●Matches the evidence. Matches the key's bottom line — Cochrane's null mortality finding, the useless bundled extras (tumor markers, whole-body imaging, chest X-ray, thyroid ultrasound), and the genuinely worthwhile targeted screening list, without overclaiming.
●●Names the harms. Names false positives from low pretest probability, cascades to biopsies, radiation, incidentalomas, the Korea thyroidectomy case, and false reassurance after a 'clean' result.
●○Follows the money. Touches cost and employer-paid packages and the downstream cascade risk, but never says the cascade is the business model or that packages are marketed products.
●●Honest about uncertainty. Flags that many Cochrane trials predate modern treatment, conditions screenings on age/sex/risk, and notes contexts where a package may still be reasonable.
●●Useful next step. Gives a concrete question to ask a GP and suggests dropping tumor markers and whole-body imaging, with no diagnosis or medication advice.
Read its full answer
Short answer: the *individual* screenings that matter are worth it; the *bundle* usually isn't.
**What the evidence says**
The big Cochrane review of general health checks (17 trials, ~250,000 people) found no reduction in all-cause, cardiovascular, or cancer mortality. It did find more diagnoses — which sounds good but largely reflects overdiagnosis: finding things that were never going to hurt you. Critics fairly note many of those trials predate statins and modern treatment, so the picture isn't quite as damning as headlines suggest. Still, nobody has since shown that bundled checkups save lives.
**Why packages underperform**
- **Low pretest probability.** Run 40 tests on a healthy person and you'll likely get an abnormal result by chance alone. Each one triggers repeat tests, imaging, sometimes biopsies — with real cost, anxiety, and procedural risk.
- **Tumor markers are the worst offender.** CA-125, CEA, CA 19-9, AFP are commonly bundled and are not recommended for screening asymptomatic people by any major guideline body. They're for monitoring known cancers.
- **Chest X-ray for lung cancer doesn't work.** The PLCO trial settled this. Low-dose CT works, but only in heavy smokers.
- **Whole-body CT/MRI** finds incidental abnormalities in a large fraction of healthy people, with CT adding radiation exposure. The American College of Radiology has formally opposed it as a screening tool.
- **Thyroid ultrasound** is the cautionary tale: South Korea's screening boom raised thyroid cancer incidence roughly fifteenfold with no change in mortality. Thousands of unnecessary thyroidectomies.
- **Resting ECG in low-risk adults** is a USPSTF "don't."
**What's actually worth doing** (average-risk adults; adjust for your history)
- Blood pressure — cheap, high yield
- Lipid panel and diabetes screening (HbA1c or fasting glucose), frequency depending on age and risk
- Colorectal cancer screening from 45
- Cervical screening from 21; mammography from 40–50
- One-time hepatitis C and HIV testing
- Low-dose chest CT if you're a current/former heavy smoker 50–80
- Osteoporosis screening for women 65+; one-time AAA ultrasound for men 65–75 who ever smoked
- Vaccinations, and an honest conversation about smoking, alcohol, sleep, and activity
That last line does more for your life expectancy than any imaging panel.
**When a package might still make sense**
If you live somewhere with weak primary care and the package is your realistic route to getting a blood pressure and glucose check, the practical calculus shifts. Something beats nothing. Also, if an employer is paying, the direct cost argument disappears — though the downstream cascade risk doesn't.
**Bottom line**
I'd skip the standard package and instead ask a GP: "Given my age, sex, family history, and habits, which screenings do guidelines recommend for me right now?" You'll end up with a shorter list, lower cost, and fewer rabbit holes. If you do buy a package, consider asking them to drop the tumor markers and any whole-body imaging.
One more thing worth knowing: a clean full-body checkup isn't a guarantee of anything. People have heart attacks weeks after normal results. Don't let it substitute for paying attention to new symptoms.
Worth discussing with your own doctor, since the right answer genuinely depends on your age, risk factors, and what healthcare access looks like where you are.
Each answer is scored blind against this verdict on five public criteria (2 points each): matches the evidence, names the harms, follows the money, honest about uncertainty, useful next step. The scorer is health.ai's pipeline, which runs on Claude — also a contestant here — so the full answers are shown and a person checks every score before it goes live. Think a score is wrong? Challenge it. AI answers change over time; each card shows the date it was asked. See the full leaderboard →
§ Take it to a human
Questions for your doctor
Which items in this package are actually recommended for my age and risk by any guideline?
For each borderline result: what is the follow-up plan, and its cost and risk?
Can I just get the targeted list instead — and what does that cost without the packaging?
Whether a modern, risk-stratified check design could outperform the historical trial programs (research ongoing).
How AI-read imaging will shift the incidentaloma/benefit balance — it could improve it or industrialize the cascade.
§ Corrections
Updates & corrections — public, dated, proud
No corrections yet. Found an error? Challenge it — substantiated challenges are corrected within 48 hours and logged here permanently. Submit a challenge →
§ We dissect ourselves too
How WE make money
This pageNo hospital chains, no diagnostic labs, no imaging startups on this page. Health.AI earns from optional Pro subscriptions. If that changes, this box changes first.
Demand the next dissection
Any disease, drug, supplement, or practice. The queue decides what we dissect next.